Report Detail
Global Sevelamer Market Insights, Forecast to 2025
- RnM3521246 |
- 14 June, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Sevelamer (rINN) is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is currently marketed by Sanofi under the trade names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate).
The global Sevelamer market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Sevelamer market based on company, product type, end user and key regions.
This report studies the global market size of Sevelamer in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Sevelamer in these regions.
This research report categorizes the global Sevelamer market by top players/brands, region, type and end user. This report also studies the global Sevelamer market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sanofi
Impax Laboratories
InvaGen Pharmaceuticals
Dr. Reddy's Laboratories
Aurobindo Pharma
Amneal Pharmaceuticals
Market size by Product
Tablet
Oral suspension
Market size by End User
Adult
Pediatric
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Sevelamer market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Sevelamer market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Sevelamer companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Sevelamer submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Sevelamer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Sevelamer market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Sevelamer Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Sevelamer Market Size Growth Rate by Product
- 1.4.2 Tablet
- 1.4.3 Oral suspension
- 1.5 Market by End User
- 1.5.1 Global Sevelamer Market Size Growth Rate by End User
- 1.5.2 Adult
- 1.5.3 Pediatric
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Sevelamer Market Size
- 2.1.1 Global Sevelamer Revenue 2014-2025
- 2.1.2 Global Sevelamer Sales 2014-2025
- 2.2 Sevelamer Growth Rate by Regions
- 2.2.1 Global Sevelamer Sales by Regions
- 2.2.2 Global Sevelamer Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Sevelamer Sales by Manufacturers
- 3.1.1 Sevelamer Sales by Manufacturers
- 3.1.2 Sevelamer Sales Market Share by Manufacturers
- 3.1.3 Global Sevelamer Market Concentration Ratio (CR5 and HHI)
- 3.2 Sevelamer Revenue by Manufacturers
- 3.2.1 Sevelamer Revenue by Manufacturers (2014-2019)
- 3.2.2 Sevelamer Revenue Share by Manufacturers (2014-2019)
- 3.3 Sevelamer Price by Manufacturers
- 3.4 Sevelamer Manufacturing Base Distribution, Product Types
- 3.4.1 Sevelamer Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Sevelamer Product Type
- 3.4.3 Date of International Manufacturers Enter into Sevelamer Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Sevelamer Sales by Product
- 4.2 Global Sevelamer Revenue by Product
- 4.3 Sevelamer Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Sevelamer Breakdown Data by End User
6 North America
- 6.1 North America Sevelamer by Countries
- 6.1.1 North America Sevelamer Sales by Countries
- 6.1.2 North America Sevelamer Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Sevelamer by Product
- 6.3 North America Sevelamer by End User
7 Europe
- 7.1 Europe Sevelamer by Countries
- 7.1.1 Europe Sevelamer Sales by Countries
- 7.1.2 Europe Sevelamer Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Sevelamer by Product
- 7.3 Europe Sevelamer by End User
8 Asia Pacific
- 8.1 Asia Pacific Sevelamer by Countries
- 8.1.1 Asia Pacific Sevelamer Sales by Countries
- 8.1.2 Asia Pacific Sevelamer Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Sevelamer by Product
- 8.3 Asia Pacific Sevelamer by End User
9 Central & South America
- 9.1 Central & South America Sevelamer by Countries
- 9.1.1 Central & South America Sevelamer Sales by Countries
- 9.1.2 Central & South America Sevelamer Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Sevelamer by Product
- 9.3 Central & South America Sevelamer by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Sevelamer by Countries
- 10.1.1 Middle East and Africa Sevelamer Sales by Countries
- 10.1.2 Middle East and Africa Sevelamer Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Sevelamer by Product
- 10.3 Middle East and Africa Sevelamer by End User
11 Company Profiles
- 11.1 Sanofi
- 11.1.1 Sanofi Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Sanofi Sevelamer Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Sanofi Sevelamer Products Offered
- 11.1.5 Sanofi Recent Development
- 11.2 Impax Laboratories
- 11.2.1 Impax Laboratories Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Impax Laboratories Sevelamer Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Impax Laboratories Sevelamer Products Offered
- 11.2.5 Impax Laboratories Recent Development
- 11.3 InvaGen Pharmaceuticals
- 11.3.1 InvaGen Pharmaceuticals Company Details
- 11.3.2 Company Business Overview
- 11.3.3 InvaGen Pharmaceuticals Sevelamer Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 InvaGen Pharmaceuticals Sevelamer Products Offered
- 11.3.5 InvaGen Pharmaceuticals Recent Development
- 11.4 Dr. Reddy's Laboratories
- 11.4.1 Dr. Reddy's Laboratories Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Dr. Reddy's Laboratories Sevelamer Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Dr. Reddy's Laboratories Sevelamer Products Offered
- 11.4.5 Dr. Reddy's Laboratories Recent Development
- 11.5 Aurobindo Pharma
- 11.5.1 Aurobindo Pharma Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Aurobindo Pharma Sevelamer Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Aurobindo Pharma Sevelamer Products Offered
- 11.5.5 Aurobindo Pharma Recent Development
- 11.6 Amneal Pharmaceuticals
- 11.6.1 Amneal Pharmaceuticals Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Amneal Pharmaceuticals Sevelamer Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Amneal Pharmaceuticals Sevelamer Products Offered
- 11.6.5 Amneal Pharmaceuticals Recent Development
12 Future Forecast
- 12.1 Sevelamer Market Forecast by Regions
- 12.1.1 Global Sevelamer Sales Forecast by Regions 2019-2025
- 12.1.2 Global Sevelamer Revenue Forecast by Regions 2019-2025
- 12.2 Sevelamer Market Forecast by Product
- 12.2.1 Global Sevelamer Sales Forecast by Product 2019-2025
- 12.2.2 Global Sevelamer Revenue Forecast by Product 2019-2025
- 12.3 Sevelamer Market Forecast by End User
- 12.4 North America Sevelamer Forecast
- 12.5 Europe Sevelamer Forecast
- 12.6 Asia Pacific Sevelamer Forecast
- 12.7 Central & South America Sevelamer Forecast
- 12.8 Middle East and Africa Sevelamer Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Sevelamer Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Sevelamer. Industry analysis & Market Report on Sevelamer is a syndicated market report, published as Global Sevelamer Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Sevelamer market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
